
Blue Owl
North America, New York, United States, New York
Description
Blue Owl is an alternative asset manager that provides investors access to direct lending and GP capital solutions.
Investor Profile
Blue Owl has made 41 investments, with 26 in the past 12 months and 39% as lead.
Stage Focus
- Post Ipo Equity (24%)
- Debt Financing (22%)
- Series B (12%)
- Series C (10%)
- Post Ipo Debt (10%)
- Series A (5%)
- Series Unknown (5%)
- Private Equity (5%)
- Series F (2%)
- Series D (2%)
Country Focus
- United States (80%)
- United Kingdom (10%)
- Canada (5%)
- Spain (2%)
- Switzerland (2%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Therapeutics
- Life Science
- Medical
- Information Technology
- Financial Services
- Oncology
- Artificial Intelligence (Ai)
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.